Roth Capital Comments on Flamel Technologies SA’s FY2016 Earnings (FLML)
Flamel Technologies SA (NASDAQ:FLML) – Analysts at Roth Capital boosted their FY2016 earnings per share (EPS) estimates for shares of Flamel Technologies SA in a research report issued to clients and investors on Tuesday. Roth Capital analyst S. Henry now anticipates that the firm will earn ($0.09) per share for the year, up from their prior forecast of ($0.18). Roth Capital also issued estimates for Flamel Technologies SA’s Q4 2016 earnings at ($0.03) EPS, FY2017 earnings at $0.20 EPS and FY2018 earnings at $0.50 EPS.
A number of other brokerages have also weighed in on FLML. Leerink Swann restated an “outperform” rating and issued a $16.00 price objective on shares of Flamel Technologies SA in a report on Tuesday, September 27th. JMP Securities reiterated an “outperform” rating and set a $16.00 price target on shares of Flamel Technologies SA in a research note on Wednesday, September 28th. Finally, Zacks Investment Research upgraded shares of Flamel Technologies SA from a “hold” rating to a “buy” rating and set a $14.00 price target on the stock in a research note on Tuesday, October 18th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $17.70.
Flamel Technologies SA (NASDAQ:FLML) opened at 10.81 on Friday. Flamel Technologies SA has a 12 month low of $7.56 and a 12 month high of $15.54. The firm has a 50 day moving average of $0.00 and a 200-day moving average of $0.00.
Flamel Technologies SA (NASDAQ:FLML) last issued its quarterly earnings data on Monday, November 7th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.13. The business earned $32.10 million during the quarter, compared to the consensus estimate of $30.70 million. Flamel Technologies SA had a net margin of 18.25% and a return on equity of 17.33%. The company’s revenue was down 32.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.28 earnings per share.
In other news, Director Craig R. Stapleton bought 20,000 shares of the stock in a transaction dated Friday, August 26th. The shares were acquired at an average price of $13.76 per share, with a total value of $275,200.00. Following the completion of the acquisition, the director now directly owns 509,678 shares in the company, valued at $7,013,169.28. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Michael S. Anderson bought 5,000 shares of the stock in a transaction dated Monday, August 22nd. The stock was purchased at an average cost of $14.30 per share, for a total transaction of $71,500.00. The disclosure for this purchase can be found here. 4.45% of the stock is currently owned by company insiders.
Several hedge funds have recently modified their holdings of FLML. Janus Capital Management LLC increased its stake in shares of Flamel Technologies SA by 647.0% in the second quarter. Janus Capital Management LLC now owns 2,197,404 shares of the company’s stock valued at $25,599,000 after buying an additional 1,903,256 shares during the last quarter. Acadian Asset Management LLC increased its stake in shares of Flamel Technologies SA by 240.2% in the second quarter. Acadian Asset Management LLC now owns 1,617,223 shares of the company’s stock valued at $17,372,000 after buying an additional 1,141,783 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of Flamel Technologies SA during the second quarter valued at $6,530,000. Ghost Tree Capital LLC purchased a new stake in shares of Flamel Technologies SA during the second quarter valued at $3,759,000. Finally, Brown Capital Management LLC increased its stake in shares of Flamel Technologies SA by 36.5% in the second quarter. Brown Capital Management LLC now owns 790,206 shares of the company’s stock valued at $8,487,000 after buying an additional 211,392 shares during the last quarter. 70.42% of the stock is currently owned by institutional investors and hedge funds.
About Flamel Technologies SA
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Receive News & Stock Ratings for Flamel Technologies SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies SA and related stocks with our FREE daily email newsletter.